New hope for hard-to-treat cancers: targeted drug shows promise in advanced tumors
NCT ID NCT06271837
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 22 times
Summary
This study tests a drug called trastuzumab deruxtecan (T-DXd) alone or with other medicines in people with advanced solid tumors that have a specific marker (HER2). The goal is to see if the drug can shrink tumors and control the disease. About 127 adults with tumors that cannot be surgically removed or have spread will take part. The study is not a cure, but aims to manage the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS (EXCLUDING GASTRIC CANCER AND BREAST CANCER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Beijing, 100142, China
-
Research Site
Beijing, 100191, China
-
Research Site
Changchun, 130021, China
-
Research Site
Changsha, 410013, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chongqing, 400030, China
-
Research Site
Dongyang, 322100, China
-
Research Site
Guangzhou, 510145, China
-
Research Site
Guangzhou, 510630, China
-
Research Site
Hangzhou, 310003, China
-
Research Site
Hangzhou, 310016, China
-
Research Site
Hangzhou, 310022, China
-
Research Site
Harbin, 150081, China
-
Research Site
Hefei, 230031, China
-
Research Site
Kunming, 650118, China
-
Research Site
Lishui, 323000, China
-
Research Site
Nanchang, 330029, China
-
Research Site
Shandong, China
-
Research Site
Shanghai, 200001, China
-
Research Site
Shanghai, 200011, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Shenyang, 110016, China
-
Research Site
Taiyuan, 030001, China
-
Research Site
Wuhan, 430022, China
-
Research Site
Xi'an, 710061, China
-
Research Site
Xuzhou, 221009, China
-
Research Site
Yinchuan, 750004, China
-
Research Site
Zhengzhou, 450002, China
-
Research Site
Zhengzhou, 450008, China
Conditions
Explore the condition pages connected to this study.